10-Q

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

0001193125-19-219048.txt : 20190812 0001193125-19-219048.hdr.sgml : 20190812 20190812163248 ACCESSION NUMBER: 0001193125-19-219048 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190812 DATE AS OF CHANGE: 20190812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARYA SCIENCES ACQUISITION CORP. CENTRAL INDEX KEY: 0001746037 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38688 FILM NUMBER: 191016908 BUSINESS ADDRESS: STREET 1: C/O PERCEPTIVE ADVISORS STREET 2: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 2122842300 MAIL ADDRESS: STREET 1: C/O PERCEPTIVE ADVISORS STREET 2: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 10-Q 1 d769016d10q.htm 10-Q 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

ARYA SCIENCES ACQUISITION CORP.

(Exact name of registrant as specified in its charter)


Cayman Islands	001-38688	98-1436307
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification Number)

51 Astor Place, 10th Floor New York, NY		10003
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (212) 284-2300

Not Applicable

(Former name or former address, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class:	Trading Symbol:	Name of Each Exchange on Which Registered:
Class A ordinary shares included as part of the units	ARYA	The NASDAQ Stock Market LLC
Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	ARYAW	The NASDAQ Stock Market LLC
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant	ARYAU	The NASDAQ Stock Market LLC

As of August 12, 2019, 14,375,000 Class A ordinary shares, par value $0.0001 per share, and 3,593,750 Class B ordinary shares, par value $0.0001 per share, were issued and outstanding, respectively.

ARYA SCIENCES ACQUISITION CORP.

Form 10-Q

For the Quarter Ended June 30, 2019

Table of Contents


		Page
PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)		1

	Condensed Balance Sheets as of June 30, 2019 (Unaudited) and December 31, 2018	1

	Unaudited Condensed Statements of Operations for the three and six months ended June 30, 2019	2

	Unaudited Condensed Statement of Changes in Shareholders’ Equity for the six months ended June 30, 2019	3

	Unaudited Condensed Statement of Cash Flows for the six months ended June 30, 2019	4

	Notes to Unaudited Condensed Financial Statements	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		15

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		18

Item 4.	Controls and Procedures		18

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings		19

Item 1A.	Risk Factors		19

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities		19

Item 3.	Defaults Upon Senior Securities		19

Item 4.	Mine Safety Disclosures		19

Item 5.	Other Information		19

Item 6.	Exhibits		20

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements (Unaudited)

ARYA SCIENCES ACQUISITION CORP.

CONDENSED BALANCE SHEETS


	June 30, 2019		December 31, 2018
	(Unaudited)
Assets:
Current assets:
Cash	$	1,015,506	$	1,198,306
Prepaid expenses		114,384		133,966

Total current assets		1,129,890		1,332,272
Investments held in Trust Account		146,305,986		144,488,284

Total assets	$	147,435,876	$	145,820,556

Liabilities and Shareholders’ Equity:
Current liabilities:
Accounts payable	$	1,381	$	—
Accrued expenses		43,012		5,000

Total current liabilities		44,393		5,000
Deferred underwriting commissions		4,671,875		4,671,875

Total liabilities		4,716,268		4,676,875

Commitments

Class A ordinary shares, $0.0001 par value; 13,771,960 and 13,614,368 shares subject to possible redemption at redemption value at June 30, 2019 and December 31, 2018, respectively		137,719,600		136,143,680

Shareholders’ Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—		—
Class A ordinary shares, $0.0001 par value; 479,000,000 shares authorized; 603,040 and 760,632 shares issued and outstanding (excluding 13,771,960 and 13,614,368 shares subject to possible redemption) at June 30, 2019 and December 31, 2018, respectively		60		76

Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 3,593,750 shares issued and outstanding at June 30, 2019 and December 31, 2018		359		359
Additional paid-in capital		2,797,062		4,372,966
Retained earnings		2,202,527		626,600

Total shareholders’ equity		5,000,008		5,000,001

Total Liabilities and Shareholders’ Equity	$	147,435,876	$	145,820,556

The accompanying notes are an integral part of these unaudited interim condensed financial statements.

ARYA SCIENCES ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS


	For the three months ended			For the six months ended
	June 30, 2019			June 30, 2019
General and administrative costs	$	88,205		$	241,775

Loss from operations		(88,205	)		(241,775	)
Investment income on Trust Account		945,367			1,817,702

Net income	$	857,162		$	1,575,927

Weighted average shares outstanding of Class A ordinary shares		14,375,000			14,375,000

Basic and diluted net income per share, Class A	$	0.07		$	0.13

Weighted average shares outstanding of Class B ordinary shares		3,593,750			3,593,750

Basic and diluted net loss per share, Class B	$	(0.02	)	$	(0.07	)

The accompanying notes are an integral part of these unaudited interim condensed financial statements.

ARYA SCIENCES ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY


	For the six months ended June 30, 2019
	Ordinary Shares															Total
	Class A						Class B				Additional Paid-In			Retained		Shareholders’
	Shares			Amount			Shares		Amount		Capital			Earnings		Equity
Balance - December 31, 2018		760,632		$	76			3,593,750	$	359	$	4,372,966		$	626,600	$	5,000,001

Ordinary shares subject to possible redemption		(71,876	)		(7	)		—		—		(718,753	)		—		(718,760	)
Net income		—			—			—		—		—			718,765		718,765

Balance - March 31, 2019 (unaudited)		688,756		$	69			3,593,750	$	359	$	3,654,213		$	1,345,365	$	5,000,006

Ordinary shares subject to possible redemption		(85,716	)		(9	)		—		—		(857,151	)		—		(857,160	)
Net income		—			—			—		—		—			857,162		857,162

Balance - June 30, 2019 (unaudited)		603,040		$	60			3,593,750	$	359	$	2,797,062		$	2,202,527	$	5,000,008

The accompanying notes are an integral part of these unaudited interim condensed financial statements.

ARYA SCIENCES ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS


	For the six months ended June 30, 2019
Cash Flows from Operating Activities:
Net income	$	1,575,927
Adjustments to reconcile net income to net cash used in operating activities:
Income earned on investment held in Trust Account		(1,817,702	)
Changes in operating assets and liabilities:
Prepaid expenses		19,582
Accounts payable		1,381
Accrued expenses		38,012

Net cash used in operating activities		(182,800	)

Net change in cash		(182,800	)

Cash - beginning of the period		1,198,306

Cash - end of the period	$	1,015,506

Supplemental disclosure of noncash activities:
Value of Class A ordinary shares subject to possible redemption	$	1,575,920

The accompanying notes are an integral part of these unaudited interim condensed financial statements.

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 1 — Description of Organization, Business Operations and Basis of Presentation

ARYA Sciences Acquisition Corp. (the “Company”) is a newly organized blank check company incorporated on June 29, 2018 (inception) as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it focuses on industries that complement its management team’s background, and in its search for targets for its Business Combination capitalizes on the ability of its management team to identify and acquire a business, focusing on the healthcare or healthcare related industries. In particular, the Company is targeting North American or European companies in the biotech, pharmaceutical, medical device and therapeutics subsectors where its management has extensive investment experience. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

As of June 30, 2019, the Company had not commenced any operations. All activity for the period from June 29, 2018 (inception) to June 30, 2019 relates to the Company’s formation, the preparation for the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, the search for a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and investments from the proceeds derived from the Initial Public Offering. The Company had no operating activities during the period from June 29, 2018 (inception) to June 30, 2018.

The Company’s sponsor is ARYA Sciences Holdings, a Cayman Islands exempted limited company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on October 4, 2018. On October 10, 2018, the Company consummated the Initial Public Offering, and offered and sold 14,375,000 units (each, a “Unit” and collectively, the “Units”) for $10.00 per Unit, which is discussed in Note 3, generating gross proceeds of $143.75 million, and incurring offering costs of approximately $9.2 million, inclusive of approximately $4.672 million in deferred underwriting commissions (Note 5).

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (the “Private Placement”) of 5,953,125 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds of approximately $5.95 million (Note 4).

Upon the closing of the Initial Public Offering and the Private Placement, $143.75 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (the “Trust Account”), located in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and will only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the assets held in the Trust Account as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

The Company will provide the holders of its outstanding Class A ordinary shares, par value $0.0001 (the “Class A ordinary shares”), sold in the Initial Public Offering (the “Public Shareholders”) with the opportunity to redeem all

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

or a portion of their Public Shares (as defined in Note 3) upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed to vote their Founder Shares (as defined in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares and any Public Shares acquired by them in connection with the completion of a Business Combination.

Notwithstanding the foregoing, the Company’s amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the amended and restated memorandum and articles of association that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below), unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or October 10, 2020 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only the $10.00 per share initially held in the Trust Account (or less than that in certain circumstances). In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by third parties, including any vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all third parties, including vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Basis of Presentation

The accompanying unaudited interim condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2019 are not necessarily indicative of the results that may be expected through December 31, 2019. The Company had no activities during the period from June 29, 2018 (inception) to June 30, 2018.

The accompanying unaudited interim condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 25, 2019.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Liquidity and Capital Resources

At June 30, 2019, the Company had approximately $1.0 million in its operating bank account, and working capital of approximately $1.1 million. The Company’s liquidity needs have been satisfied to date through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares to the Sponsor, approximately $148,000 pursuant to a note payable to related parties, and certain of the proceeds of the Private Placement not held in the Trust Account. The Company repaid the note back to the Sponsor in October 2018.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet the Company’s needs through the earlier of the consummation of an initial Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the initial Business Combination.

Note 2 — Summary of Significant Accounting Policies

Concentration of Credit Risk

Financial instruments that potentially subject the Company to credit risk consist principally of cash and investments held in Trust Account. Cash is maintained in accounts with financial institutions, which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on its cash accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant. The Company’s investments held in Trust Account consists entirely of U.S government securities with an original maturity of 180 days or less.

Use of Estimates

The preparation of the unaudited interim condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited interim condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Offering Costs

Offering costs of approximately $9.2 million consist of legal, accounting, underwriting fees and other costs that were directly related to the Initial Public Offering and were charged to shareholders’ equity upon the completion of the Initial Public Offering.

Class A Ordinary Shares subject to possible redemption

Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2019 and December 31, 2018, 13,771,960 and 13,614,368 Class A ordinary shares subject to possible redemption at the redemption amount are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.

Net Income (Loss) Per Ordinary Share

Net income (loss) per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of warrants sold in the Initial Public Offering and Private Placement to purchase 13,140,625 Class A ordinary shares of the Company in the calculation of diluted income per share, since their inclusion would be anti-dilutive under the treasury stock method.

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

The Company’s statement of operation includes a presentation of income per share for Class A ordinary shares subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Class A ordinary shares for the three and six months ended June 30, 2019 was calculated by dividing the interest income earned on the Trust Account of approximately $945,000 and $1.8 million, respectively, by the weighted average number of Class A ordinary shares outstanding for the period. Net loss per share, basic and diluted for Class B ordinary shares is calculated by dividing the net income, less income attributable to Public Shares, by the weighted average number of Class B ordinary shares outstanding for the period.

Fair Value of Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

As of June 30, 2019 and December 31, 2018, the carrying values of cash, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account is comprised of investments in U.S. Treasury securities with an original maturity of 180 days or less and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets.

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited interim condensed financial statements.

Note 3 — Initial Public Offering

On October 10, 2018, the Company sold 14,375,000 Units at a price of $10.00 per Unit in the Initial Public Offering. Each Unit consists of one Class A ordinary share (such Class A ordinary shares included in the Units being offered, the “Public Shares”), and one-half of one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 6).

Note 4 — Related Party Transactions

Founder Shares

On July 5, 2018, the Sponsor paid $25,000 to cover certain expenses and offering costs on behalf of the Company in consideration of 3,593,750 shares (the “Founder Shares”) of the Company’s Class B ordinary shares, par value $0.0001 per share (the “Class B ordinary shares”). Prior to the consummation of the Initial Public Offering, the Sponsor transferred 30,000 Founder Shares to each of Kevin Conroy, Dr. Todd Wider and Dr. David Hung, the Company’s independent directors. The Founder Shares will automatically convert into Class A ordinary shares at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions, as described in Note 6. The Sponsor had agreed to forfeit up to 468,750 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters. On October 10, 2018, the underwriters exercised the over-allotment option in full; thus, these Founder Shares were no longer subject to forfeiture.

The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Private Placement Warrants

Concurrently with the closing of the Initial Public Offering, the Sponsor purchased 5,953,125 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating proceeds of approximately $5.953 million in the Private Placement.

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Each Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

Related Party Loans

On July 5, 2018, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan is non-interest bearing and payable on the earlier of December 31, 2018 or the completion of the Initial Public Offering. The Sponsor paid for an aggregate of approximately $148,000 to cover for expenses on the Company’s behalf under the Note. On October 10, 2018, the Company repaid the Note in full and advanced an additional $1,524 to the Sponsor. The Sponsor repaid this advance back to the Company on October 12, 2018.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination is not completed, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2019 and December 31, 2018, there were no outstanding Working Capital Loans under this arrangement.

Administrative Support Agreement

The Company agreed, commencing on the effective date of the Initial Public Offering in October 2018 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. The Company recognized $30,000 and $60,000 in expenses incurred in connection with the aforementioned arrangements with the related parties on the Statement of Operations for the three and six months ended June 30, 2019, respectively.

Private Placement of Ordinary Shares

The Sponsor has indicated an interest to purchase up to $25.0 million of the Company’s ordinary shares in a private placement that would occur concurrently with the consummation of the initial Business Combination. The funds from such private placement would be used as part of the consideration to the sellers in the initial Business Combination, and any excess funds from such private placement would be used for working capital in the post-transaction company. However, because indications of interest are not binding agreements or commitments to purchase, the Sponsor may determine not to purchase any such shares, or to purchase fewer shares than it indicated an interest in purchasing. Furthermore, the Company is not under any obligation to sell any such shares.

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 5 — Commitments & Contingencies

Registration and Shareholder Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares into Class A ordinary shares) pursuant to a registration and shareholder rights agreement entered into in connection with the consummation of the Initial Public Offering. These holders are entitled to certain demand and “piggyback” registration and shareholder rights. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 1,875,000 additional Units to cover over-allotments, if any, at $10.00 per Unit, less underwriting discounts and commissions. The underwriters exercised this option in full on October 10, 2018.

The underwriters were entitled to underwriting discounts of $0.275 per Unit, or approximately $3.953 million in the aggregate, paid upon the closing of the Initial Public Offering. An additional fee of $0.325 per Unit, or approximately $4.672 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred underwriting commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Note 6 — Shareholders’ Equity

Class A Ordinary Shares — The Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share on each matter on which they are entitled to vote. As of June 30, 2019 and December 31, 2018, there were 14,375,000 Class A ordinary shares issued or outstanding, including 13,771,960 and 13,614,368 Class A ordinary shares subject to possible redemption, respectively.

Class B Ordinary Shares — The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters submitted to vote, except as required by law. Holders of Class B ordinary shares are entitled to one vote for each share. As of June 30, 2019 and December 31, 2018, there were 3,593,750 Class B ordinary shares outstanding.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20.0% of the sum of (i) the total number of Class A ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of (a) the total number of Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination or any warrants issued to the Sponsor upon conversion of Working Capital Loans), minus (b) the number of Public Shares redeemed by Public Shareholders in connection with the initial Business Combination.

Preference Shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share, and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2019 and December 31, 2018, there were no preference shares issued or outstanding.

Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) twelve months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the Public Warrants is not effective by the sixtieth (60th) day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Private Placement Warrants are identical to the Public Warrants included in the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The Company may call the Public Warrants for redemption:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption; and

•

if, and only if, the last reported closing price of the ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

The exercise price and number of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrant shares. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Note 7 — Fair Value Measurements

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2019 and December 31, 2018 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

ARYA SCIENCES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

June 30, 2019


Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Investments held in Trust Account	$	146,305,986		—		—

December 31, 2018


Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Investments held in Trust Account	$	144,488,284		—		—

Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels of the hierarchy for the three and six months ended June 30, 2019. Level 1 instruments include investments U.S. Treasury securities with an original maturity of 180 days or less.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “ARYA Sciences Acquisition Corp.,” “our,” “us” or “we” refer to ARYA Sciences Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

Overview

We are a blank check company incorporated on June 29, 2018 (inception) as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we focus on industries that complement our management team’s background, and in our search for targets for our Business Combination seek to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare related industries. In particular, we are targeting North American or European companies in the biotech, pharmaceutical, medical device and therapeutics subsectors where our management has extensive investment experience. Our Sponsor is ARYA Sciences Holdings, a Cayman Islands exempted limited company.

The registration statement for our Initial Public Offering was declared effective on October 4, 2018. On October 10, 2018, we consummated the Initial Public Offering of 14,375,000 Units at $10.00 per Unit, generating gross proceeds of $143.75 million, and incurring offering costs of approximately $9.2 million, inclusive of approximately $4.672 million in deferred underwriting commissions. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment.

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement of 5,953,125 Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the sponsor, generating gross proceeds of approximately $5.95 million. Each Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share.

Upon the closing of the Initial Public Offering and Private Placement, $143.75 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in the Trust Account, located in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and will only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by us meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the assets held in the Trust Account. Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement, although substantially all of the net proceeds are intended to be applied toward consummating an initial Business Combination.

If we are unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or October 10, 2020, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay for our income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of our company, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

Liquidity and Capital Resources

At June 30, 2019, we had approximately $1.0 million in our operating bank account, and a working capital of approximately $1.1 million.

Our liquidity needs have been satisfied to date through receipt of a $25,000 capital contribution from our Sponsor in exchange for the issuance of the Founder Shares to our Sponsor, approximately $148,000 pursuant to a note payable to related parties, and certain of the proceeds of the Private Placement not held in the Trust Account. We repaid the note to the Sponsor in October 2018.

Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity to meet our needs through the earlier of the consummation of an initial Business Combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the initial Business Combination.

Critical Accounting Policy

Class A Ordinary Shares Subject to Possible Redemption

Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2019 and December 31, 2018, 13,771,960 and 13,614,368 Class A ordinary shares subject to possible redemption at the redemption amount are presented as temporary equity, outside of the shareholders’ equity section of our balance sheets.

Net Income (Loss) Per Ordinary Share

Net income (loss) per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. We have not considered the effect of warrants sold in the Initial Public Offering and Private Placement to purchase 13,140,625 Class A ordinary shares in the calculation of diluted income per share, since their inclusion would be anti-dilutive under the treasury stock method.

Our statement of operation includes a presentation of income per share for Class A ordinary shares subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Class A ordinary shares for the three and six months was calculated by dividing the interest income earned on the Trust Account of approximately $945,000 and $1.8 million, by the weighted average number of Class A ordinary shares outstanding for the period. Net loss per share, basic and diluted for Class B ordinary shares is calculated by dividing the net income, less income attributable to Public Shares, by the weighted average number of Class B ordinary shares outstanding for the period.

Fair Value of Financial Instruments

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Results of Operations

All activity up to June 30, 2019 was in preparation for our formation, the Initial Public Offering and, since the closing of our Initial Public Offering, a search for initial Business Combination candidates. We will not be generating any operating revenues until the closing and completion of our initial Business Combination.

For the three months ended June 30, 2019, we had net income of approximately $857,000, which consisted of approximately $945,000 in investment income, offset by approximately $88,000 in general and administrative costs.

For the six months ended June 30, 2019, we had net income of approximately $1.6 million, which consisted of approximately $1.8 million in investment income, offset by approximately $242,000 in general and administrative costs.

Contractual Obligations

Registration and Shareholder Rights

The holders of Founder Shares, Private Placement Warrants and Public Warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the founder shares, only after conversion of such shares into Class A ordinary shares) pursuant to a registration and shareholder rights agreement to be entered into upon consummation of the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration and shareholder rights. However, the registration and shareholder rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

We granted the underwriters a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 1,875,000 additional Units to cover over-allotments, if any, at $10.00 per Unit, less underwriting discounts and commissions. The underwriters exercised this option in full on October 10, 2018.

The underwriters were entitled to underwriting discounts of $0.275 per Unit, or approximately $3.953 million in the aggregate, paid upon the closing of the Initial Public Offering. An additional fee of $0.325 per Unit, or approximately $4.672 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred underwriting commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Off-Balance Sheet Arrangements

As of June 30, 2019, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.

JOBS Act

On April 5, 2012, the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our financial statements may not be comparable to companies that comply with public company effective dates.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended June 30, 2019, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our chief executive officer and chief financial officer have concluded that during the period covered by this report, our disclosure controls and procedures were effective.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2019 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1.

Legal Proceedings

None.

Item 1A.

Risk Factors

Not applicable.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities

Use of Proceeds

In connection with the Initial Public Offering, we incurred offering costs of approximately $9.2 million (including underwriting commissions of approximately $4.0 million and deferred underwriting commissions of approximately $4.7 million). Other incurred offering costs consisted principally preparation fees related to the Initial Public Offering. The Sponsor had agreed to loan us an aggregate of up to $300,000 pursuant to the Note. This loan is non-interest bearing and payable on the earlier of December 31, 2018 or the completion of the Initial Public Offering. On October 10, 2018, we repaid the Note in full and advanced an additional $1,524 to the Sponsor. The Sponsor repaid this advance back to us on October 12, 2018.

After deducting the underwriting discounts and commissions (excluding the deferred portion of approximately $4.672 million in underwriting discounts and commissions, which amount will be payable upon consummation of the initial Business Combination, if consummated) and the Initial Public Offering expenses, $143.75 million of the net proceeds from our Initial Public Offering and certain of the proceeds from the private placement of the Private Placement Warrants (or $10.00 per Unit sold in the Initial Public Offering) was placed in the Trust Account. The net proceeds of the Initial Public Offering and certain proceeds from the sale of the Private Placement Warrants are held in the Trust Account and are invested in U.S. government treasury bills with a maturity of 180 days or less and in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

None.

Item 5.

Other Information

None.

Item 6.

Exhibits.


Exhibit Number		Description

31.1		Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.

31.2		Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.

32.1*		Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.

32.2*		Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on this 12th day of August, 2019.


ARYA SCIENCES ACQUISITION CORP.

By:		/s/ Adam Stone
Name:		Adam Stone
Title:		Chief Executive Officer and Director (Principal Executive Officer)

By:		/s/ Michael Altman
Name:		Michael Altman
Title:		Chief Financial Officer and Director (Principal Financial and Accounting Officer)

EX-31.1 2 d769016dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Adam Stone, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 of ARYA Sciences Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

EX-31.2 3 d769016dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael Altman, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 of ARYA Sciences Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

EX-32.1 4 d769016dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of ARYA Sciences Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended June 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Adam Stone, Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 12, 2019

EX-32.2 5 d769016dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of ARYA Sciences Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended June 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Altman, Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 12, 2019

EX-101.INS 6 arya-20190630.xml XBRL INSTANCE DOCUMENT 0001746037 2019-04-01 2019-06-30 0001746037 2019-01-01 2019-06-30 0001746037 2019-06-30 0001746037 2018-12-31 0001746037 2019-01-01 2019-03-31 0001746037 2018-10-01 2018-10-10 0001746037 2019-03-31 0001746037 us-gaap:CommonClassAMember 2019-01-01 2019-06-30 0001746037 arya:UnderwritersMember 2019-01-01 2019-06-30 0001746037 us-gaap:IPOMember 2019-01-01 2019-06-30 0001746037 arya:SponsorMember us-gaap:PrivatePlacementMember 2019-01-01 2019-06-30 0001746037 us-gaap:CommonClassBMember 2019-01-01 2019-06-30 0001746037 arya:TrustAccountMember 2019-01-01 2019-06-30 0001746037 us-gaap:PrivatePlacementMember 2019-01-01 2019-06-30 0001746037 arya:PublicShareholderMember 2019-01-01 2019-06-30 0001746037 arya:InitialShareholdersMember 2019-01-01 2019-06-30 0001746037 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001746037 arya:UnitsMember 2019-01-01 2019-06-30 0001746037 us-gaap:CommonClassAMember 2019-01-01 2019-03-31 0001746037 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001746037 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001746037 arya:FounderSharesMember 2018-07-01 2018-07-05 0001746037 arya:KevinConroyMember 2018-07-01 2018-07-05 0001746037 arya:DrToddWiderMember 2018-07-01 2018-07-05 0001746037 arya:DrDavidHungMember 2018-07-01 2018-07-05 0001746037 arya:FounderSharesMember us-gaap:CommonClassBMember 2018-07-05 0001746037 us-gaap:IPOMember 2018-07-05 0001746037 us-gaap:IPOMember 2018-10-10 0001746037 arya:SponsorMember 2018-10-10 0001746037 us-gaap:IPOMember 2018-10-01 2018-10-10 0001746037 arya:SponsorMember 2018-10-15 2018-10-31 0001746037 us-gaap:CommonClassAMember 2018-12-31 0001746037 us-gaap:FairValueInputsLevel1Member 2018-12-31 0001746037 us-gaap:FairValueInputsLevel2Member 2018-12-31 0001746037 us-gaap:FairValueInputsLevel3Member 2018-12-31 0001746037 us-gaap:CommonClassBMember 2018-12-31 0001746037 us-gaap:CommonClassAMember 2019-06-30 0001746037 us-gaap:FairValueInputsLevel1Member 2019-06-30 0001746037 us-gaap:FairValueInputsLevel2Member 2019-06-30 0001746037 us-gaap:FairValueInputsLevel3Member 2019-06-30 0001746037 us-gaap:IPOMember 2019-06-30 0001746037 arya:UnderwritersMember 2019-06-30 0001746037 us-gaap:PrivatePlacementMember 2019-06-30 0001746037 us-gaap:CommonClassBMember 2019-06-30 0001746037 arya:TrustAccountMember 2019-06-30 0001746037 us-gaap:CommonClassAMember 2019-04-01 2019-06-30 0001746037 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001746037 us-gaap:CommonClassBMember 2019-04-01 2019-06-30 0001746037 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001746037 us-gaap:CommonClassAMember 2019-08-12 0001746037 us-gaap:CommonClassBMember 2019-08-12 0001746037 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001746037 us-gaap:RetainedEarningsMember 2018-12-31 0001746037 us-gaap:RetainedEarningsMember 2019-03-31 0001746037 us-gaap:CommonClassAMember 2019-03-31 0001746037 us-gaap:CommonClassBMember 2019-03-31 0001746037 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001746037 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001746037 us-gaap:RetainedEarningsMember 2019-06-30

1015506

1198306

114384

133966

1129890

1332272

146305986

144488284

147435876

145820556

1381

43012

5000

44393

5000

4671875

4716268

4676875

137719600

136143680

359

2797062

4372966

2202527

626600

5000008

5000001

147435876

145820556

0.0001

13771960

13614368

0.0001

479000000

603040

0.0001

20000000

760632

3593750

603040

760632

3593750

88205

241775

-88205

-241775

945367

1817702

857162

14375000

0.07

0.13

3593750

-0.02

-0.07

760632

3593750

359

4372966

-71876 -7 -718753

359

3654213

-85716 -9 -857151

359

2797062

626600

718765

1345365

857162

2202527

5000001

-718760

718765

5000006

-857160

688756

3593750

603040

5000008

3593750

1575927

1817702

-19582

1381

38012

-182800

1198306

1015506

1575920

<div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1 — Description of Organization, Business Operations and Basis of Presentation</div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">ARYA Sciences Acquisition Corp. (the “Company”) is a newly organized blank check company incorporated on June 29, 2018 (inception) as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it focuses on industries that complement its management team’s background, and in its search for targets for its Business Combination capitalizes on the ability of its management team to identify and acquire a business, focusing on the healthcare or healthcare related industries. In particular, the Company is targeting North American or European companies in the biotech, pharmaceutical, medical device and therapeutics subsectors where its management has extensive investment experience. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of June 30, 2019, the Company had not commenced any operations. All activity for the period from June 29, 2018 (inception) to June 30, 2019 relates to the Company’s formation, the preparation for the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, the search for a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income on cash and investments from the proceeds derived from the Initial Public Offering. The Company had no operating activities during the period from June 29, 2018 (inception) to June 30, 2018.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company’s sponsor is ARYA Sciences Holdings, a Cayman Islands exempted limited company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on October 4, 2018. On October 10, 2018, the Company consummated the Initial Public Offering, and offered and sold 14,375,000 units (each, a “Unit” and collectively, the “Units”) for $10.00 per Unit, which is discussed in Note 3, generating gross proceeds of $143.75 million, and incurring offering costs of approximately $9.2 million, inclusive of approximately $4.672 million in deferred underwriting commissions (Note 5). </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (the “Private Placement”) of 5,953,125 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds of approximately $5.95 million (Note 4). </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Upon the closing of the Initial Public Offering and the Private Placement, $143.75 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (the “Trust Account”), located in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and will only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the assets held in the Trust Account as described below.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. <div style="letter-spacing: 0px; top: 0px;;display:inline;">There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</div></div></div><div style="text-indent: 4%; font-family: "times new roman"; margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will provide the holders of its outstanding Class A ordinary shares, par value $0.0001 (the “Class A ordinary shares”), sold in the Initial Public Offering (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares (as defined in Note </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3)</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5)</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">. These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed to vote their Founder Shares (as defined in Note </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4)</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares and any Public Shares acquired by them in connection with the completion of a Business Combination.</div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Notwithstanding the foregoing, <div style="letter-spacing: 0px; top: 0px;;display:inline;">the Company’s amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.</div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the amended and restated memorandum and articles of association that would affect the substance or timing of <div style="letter-spacing: 0px; top: 0px;;display:inline;">the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below), unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.</div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or October 10, 2020 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The initial shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only the $10.00 per share initially held in the Trust Account (or less than that in certain circumstances). In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by third parties, including any vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all third parties, including vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Basis of Presentation </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying unaudited interim condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2019 are not necessarily indicative of the results that may be expected through December 31, 2019. The Company had no activities during the period from June 29, 2018 (inception) to June 30, 2018.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited interim condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 25, 2019.</div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Emerging Growth Company </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div><div style="font-size: 1px; margin-top: 0px; margin-bottom: 0px; background: none;"> </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Liquidity and Capital Resources </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">At June 30, 2019, the Company had approximately $1.0 million in its operating bank account, and working capital of approximately $1.1 million. The Company’s liquidity needs have been satisfied to date through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares to the Sponsor, approximately $148,000 pursuant to a note payable to related parties, and certain of the proceeds of the Private Placement not held in the Trust Account. The Company repaid the note back to the Sponsor in October 2018.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet the Company’s needs through the earlier of the consummation of an initial Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the initial Business Combination.</div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

14375000

5953125

10.00

5000001

1.00

143750000

There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

Upon the closing of the Initial Public Offering and the Private Placement, $143.75 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (the "Trust Account"), located in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and will only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "Investment Company Act"), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the assets held in the Trust Account as described below.

the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders' rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining shareholders and the Company's board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to the Company's obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

143750000

<div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; line-height: 12pt;"><div style="font-weight:bold;display:inline;width:100%;">Note 2 — Summary of Significant Accounting Policies</div></div><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Financial instruments that potentially subject the Company to credit risk consist principally of cash and investments held in Trust Account. Cash is maintained in accounts with financial institutions, which, at times may exceed the Federal depository insurance coverage<div style="letter-spacing: 0px; top: 0px;;display:inline;"> of $250,000. </div>The Company has not experienced losses on its cash accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant. The Company’s investments held in Trust Account consists entirely of U.S government securities with an original maturity of 180 days or less.<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the unaudited interim condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited interim condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Offering Costs </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Offering costs of approximately $9.2 million consist of legal, accounting, underwriting fees and other costs that were directly related to the Initial Public Offering and were charged to shareholders’ equity upon the completion of the Initial Public Offering. </div><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Class A Ordinary Shares subject to possible redemption </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2019 and December 31, 2018, 13,771,960 and 13,614,368 Class A ordinary shares subject to possible redemption at the redemption amount are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Net Income (Loss) Per Ordinary Share </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss) per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of warrants sold in the Initial Public Offering and Private Placement to purchase 13,140,625 Class A ordinary shares of the Company in the calculation of diluted income per share, since their inclusion would be anti-dilutive under the treasury stock method. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company’s statement of operation includes a presentation of income per share for Class A ordinary shares subject to redemption in a manner similar to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method of income per share. Net income per share, basic and diluted for Class A ordinary shares for the three and six months ended June 30, 2019 was calculated by dividing the interest income earned on the Trust Account of approximately $945,000 and $1.8 million, respectively, by the weighted average number of Class A ordinary shares outstanding for the period. Net loss per share, basic and diluted for Class B ordinary shares is calculated by dividing the net income, less income attributable to Public Shares, by the weighted average number of Class B ordinary shares outstanding for the period.</div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;width:4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;;width:4%;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:top;;width:1%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;width:4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;;width:4%;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:top;;width:1%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;width:4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;;width:4%;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:top;;width:1%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of June 30, 2019 and December 31, 2018, the carrying values of cash, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account is comprised of investments in U.S. Treasury securities with an original maturity of 180 days or less and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited interim condensed financial statements.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="font-family: "times new roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Financial instruments that potentially subject the Company to credit risk consist principally of cash and investments held in Trust Account. Cash is maintained in accounts with financial institutions, which, at times may exceed the Federal depository insurance coverage<div style="letter-spacing: 0px; top: 0px;;display:inline;"> of $250,000. </div>The Company has not experienced losses on its cash accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant. The Company’s investments held in Trust Account consists entirely of U.S government securities with an original maturity of 180 days or less.<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="font-family: "times new roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Class A Ordinary Shares subject to possible redemption </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2019 and December 31, 2018, 13,771,960 and 13,614,368 Class A ordinary shares subject to possible redemption at the redemption amount are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

13140625

945000 1800000

250000

14375000

10.00

11.50

The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant.

(A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company's shareholders having the right to exchange their ordinary shares for cash, securities or other property.

1524

10000

0.0001

25000 468750

3593750

11.50

1.00 5953125

5953000

300000

148000

3953000

0.275 0.325

4672000

<div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 6 — Shareholders’ Equity </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Class</div></div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"> A Ordinary Shares</div></div> — The Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $0.0001 per share. <div style="letter-spacing: 0px; top: 0px;;display:inline;">Holders of the Company’s Class A ordinary shares are entitled to one vote for each share on each matter on which they are entitled to vote.</div> As of June 30, 2019 and December 31, 2018, there were 14,375,000 Class A ordinary shares issued or outstanding, including 13,771,960 and 13,614,368 Class A ordinary shares subject to possible redemption, respectively. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Class</div></div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"> B Ordinary Shares</div></div> — The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. <div style="letter-spacing: 0px; top: 0px;;display:inline;">Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters submitted to vote, except as required by law. Holders of Class B ordinary shares are entitled to one vote for each share.</div> As of June 30, 2019 and December 31, 2018, there were 3,593,750 Class B ordinary shares outstanding. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20.0% of the sum of <div style="letter-spacing: 0px; top: 0px;;display:inline;">(i) the total number of Class A ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of (a) the total number of Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination or any warrants issued to the Sponsor upon conversion of Working Capital Loans), minus (b) the number of Public Shares redeemed by Public Shareholders in connection with the initial Business Combination.</div></div><div style="text-indent: 4%; font-family: "times new roman"; font-size: 10pt; margin-top: 10pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Preference Shares</div></div> — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share, and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2019 and December 31, 2018, there were no preference shares issued or outstanding. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Warrants</div></div> — Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) twelve months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the Public Warrants is not effective by the sixtieth (60th) day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Private Placement Warrants are identical to the Public Warrants included in the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company may call the Public Warrants for redemption: </div></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"><div style="background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 4%;;text-align:left;;vertical-align:top;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 1%;;vertical-align:top;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"><div style="background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 4%;;text-align:left;;vertical-align:top;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 1%;;vertical-align:top;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">at a price of $<div style="letter-spacing: 0px; top: 0px;;display:inline;">0.01</div> per warrant; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"><div style="background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 4%;;text-align:left;;vertical-align:top;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 1%;;vertical-align:top;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">upon a minimum of 30 days’ prior written notice of redemption; and </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"><div style="background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 4%;;text-align:left;;vertical-align:top;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; width: 1%;;vertical-align:top;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the last reported closing price of the ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.</div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The exercise price and number of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrant shares. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

0.0001

1000000

0.01

Holders of the Company’s Class A ordinary shares are entitled to one vote for each share on each matter on which they are entitled to vote.

14375000 14375000 0.200

(i) the total number of Class A ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of (a) the total number of Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination or any warrants issued to the Sponsor upon conversion of Working Capital Loans), minus (b) the number of Public Shares redeemed by Public Shareholders in connection with the initial Business Combination.

Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters submitted to vote, except as required by law. Holders of Class B ordinary shares are entitled to one vote for each share.

<div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 7 — Fair Value Measurements </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2019 and December 31, 2018 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.</div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2019 </div></div></div><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; background: none;"><div style="background: none; letter-spacing: 0px; font-size: 12pt; text-decoration: none; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="padding: 0px; width: 62%;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div><div style="font-weight:bold;display:inline;">Quoted </div></div><div><div style="font-weight:bold;display:inline;">Prices<br/>in Active<br/>Markets</div></div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Observable<br/>Inputs</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Unobservable<br/>Inputs</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap;;vertical-align:bottom;;width:;"><div style="font-family: "times new roman"; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 1)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 2)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 3)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 62%;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; line-height: normal;">Investments held in Trust Account</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">146,305,986</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2018</div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px; background: none;"><div style="background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="padding: 0px; width: 62%;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div><div style="font-weight:bold;display:inline;">Quoted </div></div><div><div style="font-weight:bold;display:inline;">Prices<br/>in Active<br/>Markets</div></div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Observable<br/>Inputs</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Unobservable<br/>Inputs</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap;;vertical-align:bottom;;width:;"><div style="font-family: "times new roman"; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 1)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 2)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 3)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 62%;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; line-height: normal;">Investments held in Trust Account</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">144,488,284</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—  </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—  </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels of the hierarchy for the three and six months ended June 30, 2019. Level 1 instruments include investments U.S. Treasury securities with an original maturity of 180 days or less.</div><div style="font-size: 1pt; margin-top: 0px; margin-bottom: 0px; background: none;"> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2019 </div></div></div><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; background: none;"><div style="background: none; letter-spacing: 0px; font-size: 12pt; text-decoration: none; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="padding: 0px; width: 62%;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div><div style="font-weight:bold;display:inline;">Quoted </div></div><div><div style="font-weight:bold;display:inline;">Prices<br/>in Active<br/>Markets</div></div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Observable<br/>Inputs</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Unobservable<br/>Inputs</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap;;vertical-align:bottom;;width:;"><div style="font-family: "times new roman"; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 1)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 2)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 3)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 62%;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; line-height: normal;">Investments held in Trust Account</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">146,305,986</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2018</div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px; background: none;"><div style="background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="padding: 0px; width: 62%;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px; width: 7%;;vertical-align:bottom;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div><div style="font-weight:bold;display:inline;">Quoted </div></div><div><div style="font-weight:bold;display:inline;">Prices<br/>in Active<br/>Markets</div></div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Observable<br/>Inputs</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Unobservable<br/>Inputs</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap;;vertical-align:bottom;;width:;"><div style="font-family: "times new roman"; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 1)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 2)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Level 3)</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:bottom;;width:;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 62%;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; line-height: normal;">Investments held in Trust Account</div></td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">144,488,284</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—  </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; background-color: rgb(204, 238, 255); width: 7%;;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—  </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

146305986

144488284

4672000

the Company's amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

the Company's obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below), unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

30000

ARYA 14375000 3593750 NASDAQ ARYAW ARYAU NASDAQ NASDAQ Class A ordinary shares included as part of the units Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant NY 10-Q Yes false 2019-06-30 2019 Q2 ARYA SCIENCES ACQUISITION CORP. 0001746037 --12-31 Yes true Non-accelerated Filer true true false 30000 60000 At June 30, 2019, the Company had approximately $1.0 million in its operating bank account, and working capital of approximately $1.1 million. The Company’s liquidity needs have been satisfied to date through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares to the Sponsor, approximately $148,000 pursuant to a note payable to related parties, and certain of the proceeds of the Private Placement not held in the Trust Account. The Company repaid the note back to the Sponsor in October 2018. 1100000

P180D

<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;width:4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;;width:4%;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:top;;width:1%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;width:4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;;width:4%;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:top;;width:1%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px; background: none;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;width:4%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;;width:4%;">•</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;vertical-align:top;;width:1%;"> </td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;;text-align:left;;vertical-align:top;"><div style="font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of June 30, 2019 and December 31, 2018, the carrying values of cash, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account is comprised of investments in U.S. Treasury securities with an original maturity of 180 days or less and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

9200000

iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares

EX-101.SCH 7 arya-20190630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Unaudited Condensed Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Unaudited Condensed Statement of Changes in Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Unaudited Condensed Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Description of Organization, Business Operations and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Description of Organization, Business Operations and Basis of Presentation (Details) link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Initial Public Offering (Details) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Commitments & Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 arya-20190630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 arya-20190630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 arya-20190630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document Information [Table] Document Information [Line Items] Trading Symbol Entity Common Stock, Shares Outstanding Security Exchange Name Title of 12(b) Security Entity Address, State or Province Document Type Entity Interactive Data Current Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Current Reporting Status Entity Shell Company Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Class A [Member] Class A ordinary shares Class A Ordinary Shares Class A Common Stock Class A Ordinary Shares [Member] Class A Ordinary Shares [Member] Common Class B [Member] Class B ordinary shares Class B Common Stock Class B Common Stock [Member] Class B Ordinary Shares [Member] Units [Member] Units Warrant [Member] Warrant Statement of Financial Position [Abstract] Statement [Table] Statement [Line Items] Assets [Abstract] Assets, Current [Abstract] Current assets: Cash Cash Operating bank account Prepaid Expense, Current Prepaid expenses Assets, Current Total current assets Assets Held-in-trust, Noncurrent Investments held in Trust Account Investments held in Trust Account Assets Total assets Liabilities and Equity [Abstract] Liabilities and Shareholders' Equity: Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Liabilities, Current Total current liabilities Liabilities, Other than Long-term Debt, Noncurrent Deferred underwriting commissions Liabilities Total liabilities Commitments and Contingencies Commitments Redeemable Noncontrolling Interest, Equity, Carrying Amount Class A ordinary shares, $0.0001 par value; 13,771,960 and 13,614,368 shares subject to possible redemption at redemption value at June 30, 2019 and December 31, 2018, respectively Stockholders' Equity Attributable to Parent [Abstract] Shareholders' Equity: Preferred Stock, Value, Issued Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding Common Stock, Value, Issued Ordinary shares value Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Retained earnings Stockholders' Equity Attributable to Parent Total shareholders' equity Liabilities and Equity Total Liabilities and Shareholders' Equity Temporary Equity, Redemption Price Per Share Ordinary shares par value Temporary Equity, Shares Issued Shares subject to possible redemption at redemption value Shares subject to possible redemption at redemption value Subject to possible redemption Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common stock, par value Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Common stock, shares outstanding Income Statement [Abstract] General and Administrative Expense General and administrative costs Operating Income (Loss) Loss from operations Investment Income, Net Investment income on Trust Account Net Income (Loss) Attributable to Parent Net income Net income Net income Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average shares outstanding Earnings Per Share, Basic and Diluted Basic and diluted net income per share Statement of Stockholders' Equity [Abstract] Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Balance Balance Shares, Outstanding Balance, shares Balance, shares Ordinary shares subject to possible redemption Ordinary shares subject to possible redemption Common stock subject to possible redemption. Ordinary shares subject to possible redemption, shares Ordinary shares subject to possible redemption, shares Common stock subject to possible redemption, Shares. Equity Components [Axis] Equity Component [Domain] Additional Paid-in Capital [Member] Additional Paid-In Capital Retained Earnings [Member] Retained Earnings Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash used in operating activities: IncomeEarnedOnInvestmentHeldInTrustAccount Income earned on investment held in Trust Account The amount of income earned on investment held in Trust Account. Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense Prepaid expenses Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued expenses Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Cash and Cash Equivalents, Period Increase (Decrease) Net change in cash Cash and Cash Equivalents, at Carrying Value Cash - beginning of the period Cash - end of the period Noncash Investing and Financing Items [Abstract] Supplemental disclosure of noncash activities: Value of Class A ordinary shares subject to possible redemption Value of Class A ordinary shares subject to possible redemption Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Description of Organization, Business Operations and Basis of Presentation Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Public Offering [Abstract] Initial Public Offering Initial Public Offering The entire disclosure of initial public offering. Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments & Contingencies Equity [Abstract] Stockholders' Equity Note Disclosure [Text Block] Shareholders' Equity Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Use of Estimates, Policy [Policy Text Block] Use of Estimates Cost of Goods and Service [Policy Text Block] Offering Costs Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block] Class A Ordinary Shares subject to possible redemption Earnings Per Share, Policy [Policy Text Block] Net Income (Loss) Per Ordinary Share Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Schedule of fair value hierarchy of the valuation techniques Description of Organization and Business Operations (Textual) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Initial public offering of units Proceeds from Issuance Initial Public Offering Gross proceeds of offering costs Sale of Stock, Price Per Share Sale of stock, per unit Sale of stock per share Proceeds from Issuance of Private Placement Gross proceeds of private placement Gross proceeds of private placement Business Acquisition, Description of Acquired Entity Description of business acquisition equity Deferred underwriting fees Deferred underwriting fees The amount of deferred underwriting fees as on the balance sheet date. General Partners' Offering Costs Offering costs of public offering Class of Warrant or Right, Outstanding Warrants of private placement Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business combination, net tangible assets Working capital Working capital The amount of working capital. Description of liquidity and capital resources Description of liquidity and capital resources Description of liquidity and capital resources. Sale of Stock [Axis] Sale of Stock [Domain] Private Placement [Member] IPO [Member] Initial public offering [Member] Initial public offering [Member] Initial public offering [Member] Public Shareholder [Member] Initial shareholders [Member] Related Party Transaction [Axis] Related Party Transaction [Domain] Trust Account [Member] Summary of Significant Accounting Policies (Textual) Cash, FDIC Insured Amount Federal depository insurance coverage amount Earnings Per Share, Diluted Diluted income per share Interest income earned on trust account The amount of interest income earned on trust account. Long-term Debt, Term Maturity days Initial Public Offering (Textual) Sale of Stock, Number of Shares Issued in Transaction Sale of stock units Share Price Class A ordinary share price Related Party Transactions (Textual) Related Party Transaction, Description of Transaction Related party transaction, description Working capital loans, description Working capital loans, description Working capital loans description. Operating Leases, Rent Expense Monthly fee Costs and Expenses, Related Party Expenses and offering costs paid by related party under Note Stock Issued During Period, Shares, Other Issuance of ordinary shares Shares Issued, Price Per Share Ordinary share price Warrants issued to purchased shares of private placement Warrants issued to purchased shares of private placement Warrants issued to purchase shares of the private placement. Prepaid Expense Advanced additional payaments to sponsor Investment Warrants, Exercise Price Warrants price Notes Payable, Related Parties Maximum loan amount Administrative expenses Administrative expenses Administrative expenses billed by related party. Founder shares subject to forfeiture by Sponsor Founder shares subject to forfeiture by Sponsor This is shares subject to forfeiture if over-allotment is not exercised in full. Over-allotment was later exercised and these shares were no longer subject to forfeiture. Founder shares purchase price Founder shares purchase price Stock Issued During Period, Shares, Issued for Services Stock Issued During Period, Shares, Issued for Services Founder Shares [Member] Sponsor [Member] Title of Individual [Axis] Title of Individual [Domain] Kevin Conroy [Member] Dr Todd Wider [Member] Dr. Todd Wider [Member] Dr David Hung [Member] Dr. David Hung [Member] Commitments & Contingencies (Textual) Underwriting Agreement Description Underwriting Agreement Description Underwriting agreement description. Underwriting discount rate Underwriting discount rate Underwriting discount rate. Expense Related to Distribution or Servicing and Underwriting Fees Underwriting discount Underwriters [Member] Underwriters [Member] Shareholders' Equity (Textual) Sponsor owned collective percentage Sponsor owned collective percentage Sponsor owned collective percentage. Conversion of Stock, Description Description of shares conversion Class of Warrant or Right, Exercise Price of Warrants or Rights Warrant price per share Description of warrant redemption Description of warrant redemption Description of warrant redemption. Common Stock, Voting Rights Ordinary shares voting rights, description Shares issued or outstanding Shares issued or outstanding Shares issued or outstanding. Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Quoted Prices in Active Markets (Level 1) [Member] Fair Value, Inputs, Level 2 [Member] Significant Other Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 3 [Member] Significant Other Unobservable Inputs (Level 3) [Member] EX-101.PRE 11 arya-20190630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2019	Aug. 12, 2019
Document Information [Line Items]
Document Type	10-Q
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Jun. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Entity Registrant Name	ARYA SCIENCES ACQUISITION CORP.
Entity Central Index Key	0001746037
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, State or Province	NY
Class A ordinary shares
Document Information [Line Items]
Trading Symbol	ARYA
Security Exchange Name	NASDAQ
Title of 12(b) Security	Class A ordinary shares included as part of the units
Entity Common Stock, Shares Outstanding		14,375,000
Class B ordinary shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		3,593,750
Warrant
Document Information [Line Items]
Trading Symbol	ARYAW
Security Exchange Name	NASDAQ
Title of 12(b) Security	Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Units
Document Information [Line Items]
Trading Symbol	ARYAU
Security Exchange Name	NASDAQ
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets:
Cash	$ 1,015,506	$ 1,198,306
Prepaid expenses	114,384	133,966
Total current assets	1,129,890	1,332,272
Investments held in Trust Account	146,305,986	144,488,284
Total assets	147,435,876	145,820,556
Current liabilities:
Accounts payable	1,381
Accrued expenses	43,012	5,000
Total current liabilities	44,393	5,000
Deferred underwriting commissions	4,671,875	4,671,875
Total liabilities	4,716,268	4,676,875
Commitments
Class A ordinary shares, $0.0001 par value; 13,771,960 and 13,614,368 shares subject to possible redemption at redemption value at June 30, 2019 and December 31, 2018, respectively	137,719,600	136,143,680
Shareholders' Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	0
Additional paid-in capital	2,797,062	4,372,966
Retained earnings	2,202,527	626,600
Total shareholders' equity	5,000,008	5,000,001
Total Liabilities and Shareholders' Equity	147,435,876	145,820,556
Class A Ordinary Shares
Shareholders' Equity:
Ordinary shares value	60	76
Class B ordinary shares
Shareholders' Equity:
Ordinary shares value	$ 359	$ 359

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Ordinary Shares
Ordinary shares par value	$ 0.0001	$ 0.0001
Shares subject to possible redemption at redemption value	13,771,960	13,614,368
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	479,000,000	479,000,000
Common stock, shares issued	603,040	760,632
Common stock, shares outstanding	603,040	760,632
Class B ordinary shares
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	3,593,750	3,593,750
Common stock, shares outstanding	3,593,750	3,593,750

XML 15 R4.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Statements of Operations - USD ($)	3 Months Ended	6 Months Ended
Unaudited Condensed Statements of Operations - USD ($)	Jun. 30, 2019	Jun. 30, 2019
General and administrative costs	$ 88,205	$ 241,775
Loss from operations	(88,205)	(241,775)
Investment income on Trust Account	945,367	1,817,702
Net income	$ 857,162	$ 1,575,927
Class A Ordinary Shares
Weighted average shares outstanding	14,375,000	14,375,000
Basic and diluted net income per share	$ 0.07	$ 0.13
Class B ordinary shares
Weighted average shares outstanding	3,593,750	3,593,750
Basic and diluted net income per share	$ (0.02)	$ (0.07)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 16 R5.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Statement of Changes in Shareholders' Equity - USD ($)	Total	Class A Common Stock	Class B Common Stock	Additional Paid-In Capital	Retained Earnings
Balance at Dec. 31, 2018	$ 5,000,001	$ 76	$ 359	$ 4,372,966	$ 626,600
Balance, shares at Dec. 31, 2018		760,632	3,593,750
Ordinary shares subject to possible redemption	(718,760)	$ (7)		(718,753)
Ordinary shares subject to possible redemption, shares		(71,876)
Net income	718,765				718,765
Balance at Mar. 31, 2019	5,000,006	$ 69	$ 359	3,654,213	1,345,365
Balance, shares at Mar. 31, 2019		688,756	3,593,750
Balance at Dec. 31, 2018	5,000,001	$ 76	$ 359	4,372,966	626,600
Balance, shares at Dec. 31, 2018		760,632	3,593,750
Net income	1,575,927
Balance at Jun. 30, 2019	5,000,008	$ 60	$ 359	2,797,062	2,202,527
Balance, shares at Jun. 30, 2019		603,040	3,593,750
Balance at Mar. 31, 2019	5,000,006	$ 69	$ 359	3,654,213	1,345,365
Balance, shares at Mar. 31, 2019		688,756	3,593,750
Ordinary shares subject to possible redemption	(857,160)	$ (9)		(857,151)
Ordinary shares subject to possible redemption, shares		(85,716)
Net income	857,162				857,162
Balance at Jun. 30, 2019	$ 5,000,008	$ 60	$ 359	$ 2,797,062	$ 2,202,527
Balance, shares at Jun. 30, 2019		603,040	3,593,750

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Statement of Cash Flows - USD ($)	3 Months Ended		6 Months Ended
Unaudited Condensed Statement of Cash Flows - USD ($)	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2019
Cash Flows from Operating Activities:
Net income	$ 857,162	$ 718,765	$ 1,575,927
Adjustments to reconcile net income to net cash used in operating activities:
Income earned on investment held in Trust Account			(1,817,702)
Changes in operating assets and liabilities:
Prepaid expenses			19,582
Accounts payable			1,381
Accrued expenses			38,012
Net cash used in operating activities			(182,800)
Net change in cash			(182,800)
Cash - beginning of the period		$ 1,198,306	1,198,306
Cash - end of the period	$ 1,015,506		1,015,506
Supplemental disclosure of noncash activities:
Value of Class A ordinary shares subject to possible redemption			$ 1,575,920

XML 18 R7.htm IDEA: XBRL DOCUMENT

Description of Organization, Business Operations and Basis of Presentation

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Organization, Business Operations and Basis of Presentation

Note 1 — Description of Organization, Business Operations and Basis of Presentation

non-operating

income in the form of interest income on cash and investments from the proceeds derived from the Initial Public Offering. The Company had no operating activities during the period from June 29, 2018 (inception) to June 30, 2018.

2a-7

of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the assets held in the Trust Account as described below.

upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The

per-share

amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note

. These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed to vote their Founder Shares (as defined in Note

and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares and any Public Shares acquired by them in connection with the completion of a Business Combination.

Notwithstanding the foregoing,

the Company’s amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below), unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

The initial shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only the $10.00 per share initially held in the Trust Account (or less than that in certain circumstances). In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by third parties, including any vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all third parties, including vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Basis of Presentation

Emerging Growth Company

Liquidity and Capital Resources

XML 19 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

Concentration of Credit Risk

of $250,000.

The Company has not experienced losses on its cash accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant. The Company’s investments held in Trust Account consists entirely of U.S government securities with an original maturity of 180 days or less.

Use of Estimates

Offering Costs

Class A Ordinary Shares subject to possible redemption

Net Income (Loss) Per Ordinary Share

The Company’s statement of operation includes a presentation of income per share for Class A ordinary shares subject to redemption in a manner similar to the

two-class

method of income per share. Net income per share, basic and diluted for Class A ordinary shares for the three and six months ended June 30, 2019 was calculated by dividing the interest income earned on the Trust Account of approximately $945,000 and $1.8 million, respectively, by the weighted average number of Class A ordinary shares outstanding for the period. Net loss per share, basic and diluted for Class B ordinary shares is calculated by dividing the net income, less income attributable to Public Shares, by the weighted average number of Class B ordinary shares outstanding for the period.

Fair Value of Financial Instruments

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Recent Accounting Pronouncements

XML 20 R9.htm IDEA: XBRL DOCUMENT

Initial Public Offering

6 Months Ended

Jun. 30, 2019

Public Offering [Abstract]

Initial Public Offering

Note 3 — Initial Public Offering

one-half

of one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 6).

XML 21 R10.htm IDEA: XBRL DOCUMENT

Related Party Transactions

6 Months Ended

Jun. 30, 2019

Related Party Transactions

Note 4 — Related Party Transactions

Founder Shares

30,000

Founder Shares to each of Kevin Conroy, Dr. Todd Wider and Dr. David Hung, the Company’s independent directors. The Founder Shares will automatically convert into Class A ordinary shares at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions, as described in Note 6. The Sponsor had agreed to forfeit up to 468,750 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters. On October 10, 2018, the underwriters exercised the over-allotment option in full; thus, these Founder Shares were no longer subject to forfeiture.

30-trading

day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Private Placement Warrants

non-redeemable

and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

Related Party Loans

non-interest

bearing and payable on the earlier of December 31, 2018 or the completion of the Initial Public Offering. The Sponsor paid for an aggregate of approximately $148,000 to cover for expenses on the Company’s behalf under the Note. On October 10, 2018, the Company repaid the Note in full and advanced an additional $1,524 to the Sponsor. The Sponsor repaid this advance back to the Company on October 12, 2018.

The warrants would be identical to the Private Placement Warrants. As of June 30, 2019 and December 31, 2018, there were no outstanding Working Capital Loans under this arrangement.

Administrative Support Agreement

Private Placement of Ordinary Shares

. The funds from such private placement would be used as part of the consideration to the sellers in the initial Business Combination, and any excess funds from such private placement would be used for working capital in the post-transaction company. However, because indications of interest are not binding agreements or commitments to purchase, the Sponsor may determine not to purchase any such shares, or to purchase fewer shares than it indicated an interest in purchasing. Furthermore, the Company is not under any obligation to sell any such shares.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies

6 Months Ended

Jun. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments & Contingencies

Note 5 — Commitments & Contingencies

Registration and Shareholder Rights

lock-up

period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a

45-day

option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 1,875,000 additional Units to cover over-allotments, if any, at $10.00 per Unit, less underwriting discounts and commissions. The underwriters exercised this option in full on October 10, 2018.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Shareholders' Equity

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Shareholders' Equity

Note 6 — Shareholders’ Equity

Class

A Ordinary Shares

— The Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $0.0001 per share.

Holders of the Company’s Class A ordinary shares are entitled to one vote for each share on each matter on which they are entitled to vote.

As of June 30, 2019 and December 31, 2018, there were 14,375,000 Class A ordinary shares issued or outstanding, including 13,771,960 and 13,614,368 Class A ordinary shares subject to possible redemption, respectively.

Class

B Ordinary Shares

— The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share.

As of June 30, 2019 and December 31, 2018, there were 3,593,750 Class B ordinary shares outstanding.

as-converted

basis, 20.0% of the sum of

Preference Shares

— The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share, and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2019 and December 31, 2018, there were no preference shares issued or outstanding.

Warrants

— Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) twelve months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the Public Warrants is not effective by the sixtieth (60th) day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

non-redeemable

so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The Company may call the Public Warrants for redemption:

•

in whole and not in part;

•

at a price of $

0.01

per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption; and

•

if, and only if, the last reported closing price of the ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a

30-trading

day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

6 Months Ended

Jun. 30, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 7 — Fair Value Measurements

June 30, 2019

Quoted

Prices
in Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

Description

(Level 1)

(Level 2)

(Level 3)

Investments held in Trust Account

146,305,986

—

December 31, 2018

Quoted

Prices
in Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

Description

(Level 1)

(Level 2)

(Level 3)

Investments held in Trust Account

144,488,284

—

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 25 R14.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Concentration of Credit Risk

of $250,000.

Use of Estimates

Offering Costs

Class A Ordinary Shares subject to possible redemption

Net Income (Loss) Per Ordinary Share

The Company’s statement of operation includes a presentation of income per share for Class A ordinary shares subject to redemption in a manner similar to the

two-class

Fair Value Measurements

Fair Value of Financial Instruments

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Recent Accounting Pronouncements

XML 26 R15.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2019

Fair Value Disclosures [Abstract]

Schedule of fair value hierarchy of the valuation techniques

June 30, 2019

Quoted

Prices
in Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

Description

(Level 1)

(Level 2)

(Level 3)

Investments held in Trust Account

146,305,986

—

December 31, 2018

Quoted

Prices
in Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

Description

(Level 1)

(Level 2)

(Level 3)

Investments held in Trust Account

144,488,284

—

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

XML 27 R16.htm IDEA: XBRL DOCUMENT

Description of Organization, Business Operations and Basis of Presentation (Details) - USD ($)		6 Months Ended
	Oct. 10, 2018	Jun. 30, 2019	Dec. 31, 2018
Description of Organization and Business Operations (Textual)
Gross proceeds of offering costs		$ 143,750,000
Operating bank account		1,015,506	$ 1,198,306
Working capital		$ 1,100,000
Description of liquidity and capital resources		At June 30, 2019, the Company had approximately $1.0 million in its operating bank account, and working capital of approximately $1.1 million. The Company’s liquidity needs have been satisfied to date through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares to the Sponsor, approximately $148,000 pursuant to a note payable to related parties, and certain of the proceeds of the Private Placement not held in the Trust Account. The Company repaid the note back to the Sponsor in October 2018.
Class A Ordinary Shares [Member]
Description of Organization and Business Operations (Textual)
Common stock, par value		$ 0.0001	$ 0.0001
Trust Account [Member]
Description of Organization and Business Operations (Textual)
Description of business acquisition equity		There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
Common stock, par value		$ 10.00
Business combination, net tangible assets		$ 5,000,001
Private Placement [Member]
Description of Organization and Business Operations (Textual)
Sale of stock, per unit		$ 1.00
Gross proceeds of private placement		$ 5,953,000
Description of business acquisition equity		Upon the closing of the Initial Public Offering and the Private Placement, $143.75 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (the "Trust Account"), located in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and will only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "Investment Company Act"), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the assets held in the Trust Account as described below.
Warrants of private placement		5,953,125
Initial public offering [Member]
Description of Organization and Business Operations (Textual)
Initial public offering of units	14,375,000
Gross proceeds of offering costs	$ 143,750,000
Sale of stock, per unit	$ 10.00
Description of business acquisition equity		the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders' rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining shareholders and the Company's board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to the Company's obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
Deferred underwriting fees	$ 4,672,000
Offering costs of public offering	$ 9,200,000
Public Shareholder [Member]
Description of Organization and Business Operations (Textual)
Description of business acquisition equity		the Company's amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.
Initial shareholders [Member]
Description of Organization and Business Operations (Textual)
Description of business acquisition equity		the Company's obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below), unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

XML 28 R17.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019	Dec. 31, 2018	Oct. 10, 2018
Summary of Significant Accounting Policies (Textual)
Federal depository insurance coverage amount	$ 250,000	$ 250,000
Maturity days	180 days	180 days
Initial public offering [Member]
Summary of Significant Accounting Policies (Textual)
Offering costs of public offering				$ 9,200,000
Class A Ordinary Shares
Summary of Significant Accounting Policies (Textual)
Shares subject to possible redemption at redemption value	13,771,960	13,771,960	13,614,368
Diluted income per share		$ 13,140,625
Interest income earned on trust account	$ 945,000	$ 1,800,000

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

+ Details

XML 29 R18.htm IDEA: XBRL DOCUMENT

Initial Public Offering (Details) - Initial public offering [Member]	Oct. 10, 2018 $ / shares shares
Initial Public Offering (Textual)
Sale of stock units \| shares	14,375,000
Sale of stock per share	$ 10.00
Class A ordinary share price	$ 11.50

XML 30 R19.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details) - USD ($)			1 Months Ended	3 Months Ended	6 Months Ended
Related Party Transactions (Details) - USD ($)	Oct. 10, 2018	Jul. 05, 2018	Oct. 31, 2018	Jun. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Related Party Transactions (Textual)
Working capital loans, description					The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant.
Expenses and offering costs paid by related party under Note	$ 148,000
Administrative expenses				$ 30,000	$ 60,000
Kevin Conroy [Member]
Related Party Transactions (Textual)
Stock Issued During Period, Shares, Issued for Services		30,000
Dr. Todd Wider [Member]
Related Party Transactions (Textual)
Stock Issued During Period, Shares, Issued for Services		30,000
Dr. David Hung [Member]
Related Party Transactions (Textual)
Stock Issued During Period, Shares, Issued for Services		30,000
Initial public offering [Member]
Related Party Transactions (Textual)
Maximum loan amount		$ 300,000
Private Placement [Member]
Related Party Transactions (Textual)
Gross proceeds of private placement					$ 5,953,000
Warrants issued to purchased shares of private placement					5,953,125
Warrants price					$ 1.00
Class B Common Stock [Member]
Related Party Transactions (Textual)
Common stock, par value				$ 0.0001	0.0001	$ 0.0001
Class A Ordinary Shares
Related Party Transactions (Textual)
Common stock, par value				0.0001	0.0001	$ 0.0001
Ordinary share price				$ 11.50	$ 11.50
Founder Shares [Member]
Related Party Transactions (Textual)
Related party transaction, description		(A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company's shareholders having the right to exchange their ordinary shares for cash, securities or other property.
Issuance of ordinary shares		3,593,750
Founder shares subject to forfeiture by Sponsor		468,750
Founder shares purchase price		$ 25,000
Founder Shares [Member] \| Class B Common Stock [Member]
Related Party Transactions (Textual)
Common stock, par value		$ 0.0001
Sponsor [Member]
Related Party Transactions (Textual)
Monthly fee			$ 10,000
Advanced additional payaments to sponsor	$ 1,524
Sponsor [Member] \| Private Placement [Member]
Related Party Transactions (Textual)
Related party transaction, description					The Sponsor has indicated an interest to purchase up to $25.0 million of the Company’s ordinary shares in a private placement that would occur concurrently with the consummation of the initial Business Combination

XML 31 R20.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2019 USD ($) $ / shares
Commitments & Contingencies (Textual)
Underwriting Agreement Description	The Company granted the underwriters a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 1,875,000 additional Units to cover over-allotments, if any, at $10.00 per Unit, less underwriting discounts and commissions. The underwriters exercised this option in full on October 10, 2018.
Underwriters [Member]
Commitments & Contingencies (Textual)
Underwriting discount rate \| $ / shares	$ 0.325
Underwriting discount \| $	$ 4,672
Initial public offering [Member]
Commitments & Contingencies (Textual)
Underwriting discount rate \| $ / shares	$ 0.275
Underwriting discount \| $	$ 3,953

XML 32 R21.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - $ / shares	6 Months Ended
Shareholders' Equity (Details) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Shareholders' Equity (Textual)
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Warrant price per share	$ 0.01
Description of warrant redemption	The Company granted the underwriters a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 1,875,000 additional Units to cover over-allotments, if any, at $10.00 per Unit, less underwriting discounts and commissions. The underwriters exercised this option in full on October 10, 2018.
Class A Ordinary Shares [Member]
Shareholders' Equity (Textual)
Ordinary shares voting rights, description	Holders of the Company’s Class A ordinary shares are entitled to one vote for each share on each matter on which they are entitled to vote.
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	479,000,000	479,000,000
Common stock, shares issued	603,040	760,632
Common stock, shares outstanding	603,040	760,632
Shares issued or outstanding	14,375,000	14,375,000
Subject to possible redemption	13,771,960	13,614,368
Class B Ordinary Shares [Member]
Shareholders' Equity (Textual)
Sponsor owned collective percentage	20.00%
Description of shares conversion	(i) the total number of Class A ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of (a) the total number of Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination or any warrants issued to the Sponsor upon conversion of Working Capital Loans), minus (b) the number of Public Shares redeemed by Public Shareholders in connection with the initial Business Combination.
Ordinary shares voting rights, description	Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters submitted to vote, except as required by law. Holders of Class B ordinary shares are entitled to one vote for each share.
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	3,593,750	3,593,750
Common stock, shares outstanding	3,593,750	3,593,750

XML 33 R22.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Investments held in Trust Account	$ 146,305,986	$ 144,488,284
Quoted Prices in Active Markets (Level 1) [Member]
Investments held in Trust Account	146,305,986	144,488,284
Significant Other Observable Inputs (Level 2) [Member]
Investments held in Trust Account
Significant Other Unobservable Inputs (Level 3) [Member]
Investments held in Trust Account

XML 34 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} EXCEL 35 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 37 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 59 198 1 false 20 0 false 4 false false R1.htm 1001 - Document - Document and Entity Information Sheet http://ARYA@perceptivelife.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1002 - Statement - Condensed Balance Sheets Sheet http://ARYA@perceptivelife.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://ARYA@perceptivelife.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Unaudited Condensed Statements of Operations Sheet http://ARYA@perceptivelife.com/role/UnauditedCondensedStatementsOfOperations Unaudited Condensed Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Unaudited Condensed Statement of Changes in Shareholders' Equity Sheet http://ARYA@perceptivelife.com/role/UnauditedCondensedStatementOfChangesInShareholdersEquity Unaudited Condensed Statement of Changes in Shareholders' Equity Statements 5 false false R6.htm 1006 - Statement - Unaudited Condensed Statement of Cash Flows Sheet http://ARYA@perceptivelife.com/role/UnauditedCondensedStatementOfCashFlows Unaudited Condensed Statement of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Description of Organization, Business Operations and Basis of Presentation Sheet http://ARYA@perceptivelife.com/role/DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentation Description of Organization, Business Operations and Basis of Presentation Notes 7 false false R8.htm 1008 - Disclosure - Summary of Significant Accounting Policies Sheet http://ARYA@perceptivelife.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Initial Public Offering Sheet http://ARYA@perceptivelife.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 1010 - Disclosure - Related Party Transactions Sheet http://ARYA@perceptivelife.com/role/RelatedPartyTransactions Related Party Transactions Notes 10 false false R11.htm 1011 - Disclosure - Commitments & Contingencies Sheet http://ARYA@perceptivelife.com/role/CommitmentsContingencies Commitments & Contingencies Notes 11 false false R12.htm 1012 - Disclosure - Shareholders' Equity Sheet http://ARYA@perceptivelife.com/role/ShareholdersEquity Shareholders' Equity Notes 12 false false R13.htm 1013 - Disclosure - Fair Value Measurements Sheet http://ARYA@perceptivelife.com/role/FairValueMeasurements Fair Value Measurements Notes 13 false false R14.htm 1014 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://ARYA@perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://ARYA@perceptivelife.com/role/SummaryOfSignificantAccountingPolicies 14 false false R15.htm 1015 - Disclosure - Fair Value Measurements (Tables) Sheet http://ARYA@perceptivelife.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://ARYA@perceptivelife.com/role/FairValueMeasurements 15 false false R16.htm 1016 - Disclosure - Description of Organization, Business Operations and Basis of Presentation (Details) Sheet http://ARYA@perceptivelife.com/role/DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationDetails Description of Organization, Business Operations and Basis of Presentation (Details) Details http://ARYA@perceptivelife.com/role/DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentation 16 false false R17.htm 1017 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://ARYA@perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://ARYA@perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies 17 false false R18.htm 1018 - Disclosure - Initial Public Offering (Details) Sheet http://ARYA@perceptivelife.com/role/InitialPublicOfferingDetails Initial Public Offering (Details) Details http://ARYA@perceptivelife.com/role/InitialPublicOffering 18 false false R19.htm 1019 - Disclosure - Related Party Transactions (Details) Sheet http://ARYA@perceptivelife.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://ARYA@perceptivelife.com/role/RelatedPartyTransactions 19 false false R20.htm 1020 - Disclosure - Commitments & Contingencies (Details) Sheet http://ARYA@perceptivelife.com/role/CommitmentsContingenciesDetails Commitments & Contingencies (Details) Details http://ARYA@perceptivelife.com/role/CommitmentsContingencies 20 false false R21.htm 1021 - Disclosure - Shareholders' Equity (Details) Sheet http://ARYA@perceptivelife.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://ARYA@perceptivelife.com/role/ShareholdersEquity 21 false false R22.htm 1022 - Disclosure - Fair Value Measurements (Details) Sheet http://ARYA@perceptivelife.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://ARYA@perceptivelife.com/role/FairValueMeasurementsTables 22 false false All Reports Book All Reports arya-20190630.xml arya-20190630.xsd arya-20190630_cal.xml arya-20190630_def.xml arya-20190630_lab.xml arya-20190630_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/invest/2013-01-31 http://fasb.org/us-gaap/2019-01-31 true true ZIP 39 0001193125-19-219048-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-19-219048-xbrl.zip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